Today: 26 April 2026
Legal & General share price dips into weekend as BoE decision and debt redemption loom
1 February 2026
1 min read

Legal & General share price dips into weekend as BoE decision and debt redemption loom

London, Feb 1, 2026, 09:24 GMT — Markets have closed.

  • On Jan. 30, shares ended slightly lower, down 0.23% to 265.1p.
  • The company intends to redeem the outstanding £12.7 million on a subordinated note line come Feb. 2.
  • Traders eye the Bank of England’s rate decision on Feb. 5, followed by Legal & General’s full-year results due March 11.

Legal & General Group Plc shares ended Friday down 0.23%, closing at 265.10 pence. During the session, prices fluctuated between 263.60p and 266.20p, per market data. UK markets remain closed Sunday and will reopen Monday.

The life insurer and asset manager operates in a market segment heavily influenced by rate expectations. It puts substantial money into bonds and offers retirement products, whose profitability can swing with yield fluctuations.

The spotlight now shifts to the Bank of England, set to reveal its next Bank Rate on Feb. 5. The current rate stands at 3.75%. Traders keep an eye on gilts — UK government bonds — since their yields influence pricing across many UK financial assets.

The UK’s FTSE 100 closed Friday 0.5% higher, marking its seventh consecutive month of gains. The index got a lift from a softer pound and robust bank shares. “The weaker pound is obviously beneficial for the multinationals,” said Fiona Cincotta, senior market analyst at City Index. Reuters

Legal & General is set to redeem the last £12,705,000 of its Fixed Rate Reset Subordinated Notes due 2064 on Feb. 2, according to a company notice. These subordinated notes rank below senior debt, and this move will clear out all outstanding notes.

The next key date to watch is earnings. According to the group’s financial calendar, a preliminary full-year results announcement is set for March 11 at 07:00 GMT. On that same page, shares closed at 265.1p on January 30.

UK life insurers like Aviva and Phoenix Group frequently move in step with interest rate trends as much as with their own news. This dynamic works both ways: rising yields help boost pricing on new annuities, but sharp swings can rattle the market value of their investment portfolios.

Traders will watch gilt yields and sterling closely this week, alongside shifts in global risk appetite. UK financials often react sharply when the market recalibrates its expectations around interest rates.

The risk is clear. Should the BoE push for deeper rate cuts than anticipated, insurer stocks could take a hit as their future investment income gets marked down. On top of that, a wider market stumble might put pressure on asset management fees.

As the market winds down for the weekend, all eyes shift to Monday’s open. Then comes the BoE decision on Feb. 5. Legal & General will focus on its full-year update due March 11.

Stock Market Today

  • Is Merck Stock Still Undervalued After 40% Gain in 1 Year?
    April 26, 2026, 2:07 AM EDT. Merck (MRK) shares have surged 40.2% over the past year, recently closing at $111.90. Despite short-term declines, the stock shows a 5.1% gain year-to-date. A Discounted Cash Flow (DCF) model estimates Merck's intrinsic value at $214.74, suggesting the stock trades at a 47.9% discount and may be undervalued. Merck's Price-to-Earnings (P/E) ratio stands at 15.1, reflecting market views on its earnings relative to price. These valuation models indicate that Merck could still offer attractive long-term investment prospects despite recent price volatility. Investors should consider these fundamentals beyond short-term market moves.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 26.04.2026

26 April 2026
LIVEMarkets rolling coverageStarted: April 26, 2026, 12:00 AM EDTUpdated: April 26, 2026, 2:16 AM EDT Is Merck Stock Still Undervalued After 40% Gain in 1 Year? April 26, 2026, 2:07 AM EDT. Merck (MRK) shares have surged 40.2% over the past year, recently closing at $111.90. Despite short-term declines, the stock shows a 5.1% gain year-to-date. A Discounted Cash Flow (DCF) model estimates Merck's intrinsic value at $214.74, suggesting the stock trades at a 47.9% discount and may be undervalued. Merck's Price-to-Earnings (P/E) ratio stands at 15.1, reflecting market views on its earnings relative to price. These valuation models indicate
Lockheed Martin Gets Golden Dome Opening as Profit Worries Bite

Lockheed Martin Gets Golden Dome Opening as Profit Worries Bite

26 April 2026
Lockheed Martin was named among firms awarded up to $3.2 billion for President Trump’s Golden Dome space-based missile interceptor plan, Space Systems Command said. The company reported weaker first-quarter results, with $18 billion in sales and negative free cash flow. Space Force aims to show initial interceptor capability in 2028. Golden Dome’s total cost is projected at $185 billion.
IAG share price jumps on Friday — what to watch before Monday’s open and Feb 27 results
Previous Story

IAG share price jumps on Friday — what to watch before Monday’s open and Feb 27 results

Tesco share price ends the week higher — what could move TSCO.L next
Next Story

Tesco share price ends the week higher — what could move TSCO.L next

Go toTop